Chronic urticaria in adults: state-of-the-art in the new millennium

Detalhes bibliográficos
Autor(a) principal: Criado,Paulo Ricardo
Data de Publicação: 2015
Outros Autores: Criado,Roberta Facchini Jardim, Maruta,Celina Wakisaka, Reis,Vitor Manoel Silva dos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100074
Resumo: Chronic urticaria has been explored in several investigative aspects in the new millennium, either as to its pathogenesis, its stand as an autoimmune or auto-reactive disease, the correlation with HLA-linked genetic factors, especially with class II or its interrelation with the coagulation and fibrinolysis systems. New second-generation antihistamines, which act as good symptomatic drugs, emerged and were commercialized over the last decade. Old and new drugs that may interfere with the pathophysiology of the disease, such as cyclosporine and omalizumab have been developed and used as treatments. The purpose of this article is to describe the current state of knowledge on aspects of chronic urticaria such as, pathophysiology, diagnosis and the current therapeutic approach proposed in the literature.
id SBD-1_4f03381d0274756574d1b7cee90e7d92
oai_identifier_str oai:scielo:S0365-05962015000100074
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Chronic urticaria in adults: state-of-the-art in the new millenniumAngioedemaBiological factorsColchicineCyclosporineDapsoneImmunosuppressive agentsUrticariaChronic urticaria has been explored in several investigative aspects in the new millennium, either as to its pathogenesis, its stand as an autoimmune or auto-reactive disease, the correlation with HLA-linked genetic factors, especially with class II or its interrelation with the coagulation and fibrinolysis systems. New second-generation antihistamines, which act as good symptomatic drugs, emerged and were commercialized over the last decade. Old and new drugs that may interfere with the pathophysiology of the disease, such as cyclosporine and omalizumab have been developed and used as treatments. The purpose of this article is to describe the current state of knowledge on aspects of chronic urticaria such as, pathophysiology, diagnosis and the current therapeutic approach proposed in the literature.Sociedade Brasileira de Dermatologia2015-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100074Anais Brasileiros de Dermatologia v.90 n.1 2015reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20153509info:eu-repo/semantics/openAccessCriado,Paulo RicardoCriado,Roberta Facchini JardimMaruta,Celina WakisakaReis,Vitor Manoel Silva doseng2015-02-03T00:00:00Zoai:scielo:S0365-05962015000100074Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2015-02-03T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Chronic urticaria in adults: state-of-the-art in the new millennium
title Chronic urticaria in adults: state-of-the-art in the new millennium
spellingShingle Chronic urticaria in adults: state-of-the-art in the new millennium
Criado,Paulo Ricardo
Angioedema
Biological factors
Colchicine
Cyclosporine
Dapsone
Immunosuppressive agents
Urticaria
title_short Chronic urticaria in adults: state-of-the-art in the new millennium
title_full Chronic urticaria in adults: state-of-the-art in the new millennium
title_fullStr Chronic urticaria in adults: state-of-the-art in the new millennium
title_full_unstemmed Chronic urticaria in adults: state-of-the-art in the new millennium
title_sort Chronic urticaria in adults: state-of-the-art in the new millennium
author Criado,Paulo Ricardo
author_facet Criado,Paulo Ricardo
Criado,Roberta Facchini Jardim
Maruta,Celina Wakisaka
Reis,Vitor Manoel Silva dos
author_role author
author2 Criado,Roberta Facchini Jardim
Maruta,Celina Wakisaka
Reis,Vitor Manoel Silva dos
author2_role author
author
author
dc.contributor.author.fl_str_mv Criado,Paulo Ricardo
Criado,Roberta Facchini Jardim
Maruta,Celina Wakisaka
Reis,Vitor Manoel Silva dos
dc.subject.por.fl_str_mv Angioedema
Biological factors
Colchicine
Cyclosporine
Dapsone
Immunosuppressive agents
Urticaria
topic Angioedema
Biological factors
Colchicine
Cyclosporine
Dapsone
Immunosuppressive agents
Urticaria
description Chronic urticaria has been explored in several investigative aspects in the new millennium, either as to its pathogenesis, its stand as an autoimmune or auto-reactive disease, the correlation with HLA-linked genetic factors, especially with class II or its interrelation with the coagulation and fibrinolysis systems. New second-generation antihistamines, which act as good symptomatic drugs, emerged and were commercialized over the last decade. Old and new drugs that may interfere with the pathophysiology of the disease, such as cyclosporine and omalizumab have been developed and used as treatments. The purpose of this article is to describe the current state of knowledge on aspects of chronic urticaria such as, pathophysiology, diagnosis and the current therapeutic approach proposed in the literature.
publishDate 2015
dc.date.none.fl_str_mv 2015-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100074
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100074
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20153509
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.90 n.1 2015
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126420194164736

Registros relacionados